YM 158
a dual antagonist for LTD(4) and TXA(2) receptors; structure in first source
Also Known As:
3-(4-tert-butylthiazol-2-yl)methoxy)-5'-(3-(4-chlorobenzenesulfonyl)propyl-2'-(1H-tetrazol-5-ylmethoxy)benzanilide monosodium salt monohydrate; YM-158; YM158
Networked: 3
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
1. | Arakida, Y:
2 articles
(05/2000 - 04/2000)
|
2. | Honda, K:
2 articles
(05/2000 - 04/2000)
|
3. | Miyata, K:
2 articles
(05/2000 - 04/2000)
|
4. | Morio, H:
2 articles
(05/2000 - 04/2000)
|
5. | Ohga, K:
2 articles
(05/2000 - 04/2000)
|
6. | Okada, Y:
2 articles
(05/2000 - 04/2000)
|
7. | Suwa, K:
2 articles
(05/2000 - 04/2000)
|
8. | Yamada, T:
2 articles
(05/2000 - 04/2000)
|
9. | Yokota, M:
2 articles
(05/2000 - 04/2000)
|
10. | Benoit, Patricia:
1 article
(01/2002)
|
Related Diseases
Related Drugs and Biologics